FGFR1 and ganglioglioma: The low grade glial or glioneuronal tumor cohort comprised samples with BRAF or FGFR1 gene alterations and included 11 dysembryoplastic neuroepithelial tumors, seven pilocytic astrocytomas, and two gangliogliomas.